Skip to main content

Staging Ovarian Cancer

  • Chapter
Ovarian Carcinoma
  • 142 Accesses

Abstract

Ovarian cancer is becoming a common malignancy. It has been considered a family of malignancies arising within the ovary rather than a single entity. The ovary is complex in its embryology, histology, steroidogenesis, and potential for malignancy. It is made up of germ cells, gonadal stromal cells, and cells of the mesenchymal tissue, each with its own potential to form a tumor. Although sex is determined genetically at fertilization, the ovary passes through its early phases as an indifferent organ with parallel development that could allow it to become an ovary or a testis. Alterations or imbalances during these steps of development may provide the setting for the later cellular malfunctioning that produces endocrine imbalances as well as malignancy. The ovary is unique in that it not only gives rise to a great variety of malignancies but itself is a favorite site for metastases from many other organs.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 39.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 54.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Bibliography

  • American Joint Committee for Cancer Staging and End Results Reporting Task Force on Gynecologic Sites, Staging System for Cancer at Gynecologic Sites 1979. AJCC, Chicago.

    Google Scholar 

  • Averette HE, Haskins WJ, Dudan RC, Nordqvist SRB: The ovary. In Nealon TF Jr (ed): Management of the Patient With Cancer. Saunders, Philadelphia, 1976, p. 618.

    Google Scholar 

  • Barber HRK: Ovarian cancer. Part I. CA 29: 341, 1979.

    PubMed  CAS  Google Scholar 

  • Barber HRK: Ovarian cancer. Part II. CA 30: 2, 1980.

    PubMed  CAS  Google Scholar 

  • Barber HRK, Kwon T: Current status of the treatment of gynecologic cancer by site—ovary. Cancer 38: 610, 1976.

    Article  PubMed  CAS  Google Scholar 

  • Barber HRK, Sommers SC, Snyder R, Kwon T: Histologic and nuclear grading and stromal reactions as indices for prognosis in ovarian cancer. Am J Obstet 121 (no. 6): 795, 1975.

    CAS  Google Scholar 

  • Knapp RC, Friedman EA: Aortic lymph node metastases in early ovarian cancer. Am J Obstet Gynecol 119: 1013, 1974.

    PubMed  CAS  Google Scholar 

  • Kolstad P: Prognostic indicators and staging: ovarian cancer. Adv Biosci 26: 67, 1980.

    Google Scholar 

  • Report presented by the Cancer Committee to the General Assembly of FIGO: New York, April 1970. Int J Gynecol Obstet 9: 172, 1971.

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

Copyright information

© 1993 Springer-Verlag New York, Inc.

About this chapter

Cite this chapter

Barber, H.R.K. (1993). Staging Ovarian Cancer. In: Ovarian Carcinoma. Springer, New York, NY. https://doi.org/10.1007/978-1-4613-9232-3_11

Download citation

  • DOI: https://doi.org/10.1007/978-1-4613-9232-3_11

  • Publisher Name: Springer, New York, NY

  • Print ISBN: 978-1-4613-9234-7

  • Online ISBN: 978-1-4613-9232-3

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics